{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T09:45:10Z","timestamp":1784022310710,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.pnpbp.2008.05.022","type":"journal-article","created":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T08:24:41Z","timestamp":1212308681000},"page":"1562-1566","source":"Crossref","is-referenced-by-count":40,"title":["Acute antipyschotic efficacy and side effects in schizophrenia: Association with serotonin transporter promoter genotypes"],"prefix":"10.1016","volume":"32","author":[{"given":"Vita","family":"Dol\u017ean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Serretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mandelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jure","family":"Kopriv\u0161ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matej","family":"Kastelic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanka Kores","family":"Plesni\u010dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2008.05.022_bib1","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/jnnp.2005.082024","article-title":"Genetic association studies of complex neurological diseases","volume":"77","author":"Abou-Sleiman","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.npp.1301136","article-title":"Blockade of 5-HT2a receptors reduces haloperidol-induced attenuation of reward","volume":"32","author":"Benaliouad","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib3","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1177\/0269881106072750","article-title":"Association study of olanzapine-induced weight gain and therapeutic response with SERT gene polymorphisms in female schizophrenic patients","volume":"21","author":"Bozina","year":"2007","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib4","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/1096-8628(20001204)96:6<712::AID-AJMG2>3.0.CO;2-U","article-title":"Tardive dyskinesia is not associated with the serotonin gene polymorphism (5-HTTLPR) in Chinese","volume":"96","author":"Chong","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib5","series-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/01.jcp.0000117422.05703.ae","article-title":"Dose response and dose equivalence of antipsychotics","volume":"24","author":"Davis","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib7","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1523\/JNEUROSCI.15-01-00821.1995","article-title":"Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis","volume":"15","author":"Dewey","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1017\/S1461145704004948","article-title":"Family-based association study of the 5-HT transporter gene and schizophrenia","volume":"8","author":"Dubertret","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s004390050624","article-title":"Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects","volume":"101","author":"Gelernter","year":"1997","journal-title":"Hum Genet"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/(SICI)1096-8628(19990205)88:1<61::AID-AJMG11>3.0.CO;2-K","article-title":"Population studies of polymorphisms of the serotonin transporter protein gene","volume":"88","author":"Gelernter","year":"1999","journal-title":"American Journal of Medical Genetics"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130000573","article-title":"Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice","volume":"155","author":"Gingrich","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1096-8628(19990205)88:1<83::AID-AJMG15>3.0.CO;2-0","article-title":"Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets","volume":"88","author":"Greenberg","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00228-006-0234-8","article-title":"Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms","volume":"63","author":"Guzey","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib14","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1046\/j.1471-4159.1996.66062621.x","article-title":"Allelic variation of human serotonin transporter gene expression","volume":"66","author":"Heils","year":"1996","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0924-9338(03)00005-1","article-title":"Tardive dyskinesia is not associated with the polymorphisms of 5-HT2A receptor gene, serotonin transporter gene and catechol-o-methyltransferase gene","volume":"18","author":"Herken","year":"2003","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib16","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.biopsych.2004.01.029","article-title":"Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression","volume":"55","author":"Hranilovic","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib17","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1086\/503850","article-title":"Serotonin transporter promoter gain-of-function genotypes are linked to obsessive\u2013compulsive disorder","volume":"78","author":"Hu","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-2999(96)00948-X","article-title":"Effects of serotonergic agents on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum","volume":"321","author":"Ishikane","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pnpbp.2004.08.004","article-title":"Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics","volume":"29","author":"Javors","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.mp.4000821","article-title":"Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia","volume":"6","author":"Kaiser","year":"2001","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib21","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1176\/ajp.153.4.466","article-title":"Serotonin\u2013dopamine interaction and its relevance to schizophrenia","volume":"153","author":"Kapur","year":"1996","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib22","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1176\/appi.ajp.162.7.1243","article-title":"\u201cA gene for...\u201d: the nature of gene action in psychiatric disorders","volume":"162","author":"Kendler","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib23","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.biopsych.2005.04.048","article-title":"Sequence analysis of the serotonin transporter and associations with antidepressant response","volume":"58","author":"Kraft","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib24","first-page":"253","article-title":"The role of the serotonin transporter gene in cigarette smoking","volume":"7","author":"Lerman","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0924-977X(01)00123-7","article-title":"Variation of serotonergic gene expression: neurodevelopment and the complexity of response to psychopharmacologic drugs","volume":"11","author":"Lesch","year":"2001","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib26","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1126\/science.274.5292.1527","article-title":"Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region","volume":"274","author":"Lesch","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib27","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/sj.mp.4000412","article-title":"A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics","volume":"3","author":"Malhotra","year":"1998","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0306-4522(01)00593-0","article-title":"Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group","volume":"111","author":"Nocjar","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib29","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/clinchem\/40.2.288","article-title":"Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter","volume":"40","author":"Owens","year":"1994","journal-title":"Clin Chem"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib30","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000071212","article-title":"Polymorphism of the serotonin transporter gene and symptomatic dimensions of schizophrenia in the Korean population","volume":"47","author":"Pae","year":"2003","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib31","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00702-005-0358-5","article-title":"Interaction analysis between 5-HTTLPR and TNFA-238\/-308 polymorphisms in schizophrenia","volume":"113","author":"Pae","year":"2006","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.npp.1300819","article-title":"Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress-and drug-induced dopamine release in the rat medial prefrontal cortex","volume":"31","author":"Pehek","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib33","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1086\/302449","article-title":"Use of unlinked genetic markers to detect population stratification in association studies","volume":"65","author":"Pritchard","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib34","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1126\/science.1070532","article-title":"Schizophrenia: diverse approaches to a complex disease","volume":"296","author":"Sawa","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib35","first-page":"1541","article-title":"Regional effects of MK-801 on dopamine release: effects of competitive NMDA or 5-HT2A receptor blockade","volume":"277","author":"Schmidt","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.mp.4000842","article-title":"Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia","volume":"6","author":"Segman","year":"2001","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.tpj.6500194","article-title":"Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia","volume":"3","author":"Segman","year":"2003","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0920-9964(98)00111-X","article-title":"Serotonin transporter gene is not associated with symptomatology of schizophrenia","volume":"35","author":"Serretti","year":"1999","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib39","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/0929867043456043","article-title":"New antipsychotics and schizophrenia: a review on efficacy and side effects","volume":"11","author":"Serretti","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib40","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2174\/138945006779025419","article-title":"Serotonin transporter gene variants and behaviour: a comprehensive review","volume":"7","author":"Serretti","year":"2006","journal-title":"Current Drug Targets"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.mp.4001926","article-title":"Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients","volume":"12","author":"Serretti","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib42","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s002109900202","article-title":"Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells","volume":"361","author":"Siebert","year":"2000","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/0929867043456070","article-title":"A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation","volume":"11","author":"Stahl","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib44","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00213-006-0349-8","article-title":"Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder","volume":"187","author":"Stein","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib45","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1534\/genetics.105.044065","article-title":"Directional positive selection on an allele of arbitrary dominance","volume":"172","author":"Teshima","year":"2006","journal-title":"Genetics"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib46","series-title":"HLA: genetic diversity of HLA functional and medical implication","first-page":"307","article-title":"Anthropological features of the East European region","volume":"1","author":"Tiilikainen","year":"1997"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib47","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0920-9964(99)00170-X","article-title":"Association study of a functional serotonin transporter gene polymorphism with schizophrenia, psychopathology and clozapine response","volume":"44","author":"Tsai","year":"2000","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib48","series-title":"Lenexa, American Society for Histocompatibility and Immunogenetics","first-page":"180","article-title":"Caucasian Slovenian normal. HLA 1998","author":"Vidan-Jeras","year":"1998"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2006.09.014","article-title":"Response of risperidone treatment may be associated with polymorphisms of HTT gene in Chinese schizophrenia patients","volume":"414","author":"Wang","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib50","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"Woods","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib51","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0006-8993(97)01551-5","article-title":"Effects of haloperidol metabolites on neurotransmitter uptake and release: possible role in neurotoxicity and tardive dyskinesia","volume":"788","author":"Wright","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2008.05.022_bib52","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ajmg.b.30597","article-title":"Haplotype analysis confirms association of the serotonin transporter (5-HTT) gene with schizophrenia but not with major depression","volume":"147","author":"Zaboli","year":"2008","journal-title":"Am J Med Genet B Neuropsychiatr Genet"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584608001565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584608001565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T02:49:13Z","timestamp":1588733353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584608001565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0278584608001565"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2008.05.022","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}